Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer. [electronic resource]
Producer: 20121218Description: 308-12 p. digitalISSN:- 1476-5608
- Aged
- Aged, 80 and over
- Androgen Antagonists -- therapeutic use
- Antibodies, Monoclonal, Humanized -- pharmacology
- Antineoplastic Agents, Hormonal -- therapeutic use
- Bone Density -- drug effects
- Bone Density Conservation Agents -- pharmacology
- Denosumab
- Humans
- Male
- Middle Aged
- Prostatic Neoplasms -- drug therapy
- RANK Ligand -- antagonists & inhibitors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.